Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride

Completed · Phase 1

Conditions studied: Hypogonadism, Hypogonadism, Male

In brief

The combination of testosterone and dutasteride is intended for use in hypogonadal men. This study will evaluate the bioavailability and pharmacokinetics of various doses of testosterone administered with and without dutasteride

Key facts

Study ID

NCT00400335

Run by

GlaxoSmithKline

People needed

60

Starts

2006-10-01

Last updated by the study team

2012-06-04

Who can join

Age: 18 and older, up to 50. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Are healthy.
• Have a BMI within range of 19-32 kg/m2.
• Have not taken dutasteride for one year, or finasteride for the past 3 months.
• Have a screening PSA < 2.0ng/mL.

You may not qualify if…

• Have had or have breast or prostate cancer, sleep apnea, psychiatric illness, or any other clinically significant current condition.
• Have a trigliceride level =500mg/dL.
• Have abnormal thyroid or hormone levels.
• Would donate more than 500 ML of blood over a 2 month period.
• Physician does not think it is a good idea for you to participate in the trial.
• Are unwilling to abstain from alcohol during the study.
• Have a positive urine drug screen test.
• Plan to change your smoking habits during the course of the trial.
• Have Hepatitis C, Hepatitis B, or HIV.
• Have a lab or ECG abnormality.
• Have high or low blood pressure.
• Have used of any investigational drug or device during the study or within 30 days prior to 1st dosing of study medication.

Where it is running

• GSK Investigational Site — Tacoma, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.